Abstract | AIM: MATERIAL AND METHODS: Since January 2007 isolated right ventricular assist device Levitronix CentriMag has been implanted in 16 patients. Patients were divided into 3 groups: post transplantation (post-Tx), post LVAD implantation (post-LVAD) and other cardiac procedures (OCP). Success rate of weaning from RVAD, 30-days mortality and major complications has been assessed. OUTCOMES: Distribution of implants in groups was: post-Tx 5 pts (31%), post-LVAD 6 pts (38%) and 5 in OCP group (31%). The mean support time was 12 days. Off-pump implantation was achieved in 9 pts. The device was successfully weaned in 13 (81%) patients. 30-days mortality occurred in 1 case only. CONCLUSION: Presented outcomes are encouraging for broader acceptance of the therapy. Excellent success rate has been reached in post-Tx and post-LVAD. This study emphasises decesive role of proactive approach in early indication of RVAD implantation for achieving satisfactory results.
|
Authors | I Netuka, J Malý, O Szarszoi, H Ríha, D Turek, M Urban, I Skalský, T Kotulák, Z Dorazilová, J Pirk |
Journal | Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti
(Rozhl Chir)
Vol. 90
Issue 2
Pg. 88-94
(Feb 2011)
ISSN: 0035-9351 [Print] Czech Republic |
Vernacular Title | Technika implantace a zkusenosti s docasnou mechanickou srdecní podporou pri selhání pravé komory. |
PMID | 21638844
(Publication Type: English Abstract, Journal Article)
|
Topics |
- Cardiac Surgical Procedures
(adverse effects)
- Female
- Heart Failure
(etiology, therapy)
- Heart Transplantation
(adverse effects)
- Heart-Assist Devices
- Humans
- Male
- Middle Aged
- Postoperative Care
- Ventricular Dysfunction, Right
(etiology, therapy)
|